Welcome : Guest

SteadyMed Ltd. (Israel) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about SteadyMed Ltd., which is principally involved in Specialty Pharmaceuticals Business. Illustrated with 32 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-65439
Price: $1600
Company Type: Public
Pages: 37
Date: November 2016
Market Data Tables: 32

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Analgesic Molecules......6
Table 1: Analgesic Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Aspirin, Ibuprofen, Paracetamol and Others......6
Antihypertensive Drugs......7
Table 2: Antihypertensive Drugs Market by Product in China (2105) - Percentage Share Breakdown by Value for Angiotensin II Receptor Blockers (ARBs), Beta Blocker, Calcium Channel Blocker and Others......7
Table 3: Hypertension Treatment Market by Segment in China (2015) - Percentage Share Breakdown by Value for Products to Regulate Blood Lipid Levels, and Products to Regulate Blood Sugar......8
Pulmonary Arterial Hypertension (PAH)......9
Table 4: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......9
Table 5: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......10
Table 6: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......11
Table 7: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......12
Table 8: Pulmonary Arterial Hypertension (PAH) Treatment by Type Worldwide (2015) - Percentage Breakdown by Value for Inhaled Prostacyclins, Orals (ERAs, PDE5s, Prostacyclins), and Parenteral Prostacyclins......13
Table 9: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......14
Table 10: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......15
Table 11: Pulmonary Arterial Hypertension Treatment Market by Product Segment in Japan (2015) - Percentage Share Breakdown by Value for Adcirca, Dorner, Flolan, Procylin, Revatio, and Tracleer......16
Table 12: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......17
Table 13: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......18
Pulmonary Hypertension Drugs......19
Table 14: Specialty Pulmonary Hypertension Drugs Benefit Market by Category in the US (2015) - Percentage Share Breakdown by Value for Medical Benefit and Pharmacy Benefit......19
End-Stage Renal Disease (ESRD)......20
Table 15: End-Stage Renal Disease (ESRD) Market by Cause in China (2015) - Percentage Share Breakdown by Value for Diabetic Nephropathy, Glomerular Disease, Hypertension Caused Renal Disease and Others......20
Table 16: End-Stage Renal Disease (ESRD) Cases by Diagnosis in the US (2015) - Percentage Share Breakdown by Value for Cystic Kidney, Diabetes, Glomerulonephritis, Hypertension, and Others......21
Speciality Pharmaceuticals......22
Table 17: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......22
Table 18: Speciality Drug Sales by Therapeutic Category in the US (2015) - Percentage Market Share Breakdown by Value for Anticoagulants, Cancer, Growth Deficiency, Hepatitis C, HIV, Inflammatory Conditions, Multiple Sclerosis, Pulmonary Hypertension, Respiratory Conditions, Transplant and Others......23
Table 19: Specialty Pharmaceuticals Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Hepatitis, HIV & AIDS (including oral solids), Intravenous Immunoglobulin (Hemophilia), Multiple Sclerosis, Oncology (including oral solids), Renal, Rheumatoid Arthritis (Crohn's), and Others......24
Anaesthetics & Analgesics......25
Table 20: Market Shares of Leading Anaesthetics & Analgesics Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......25
Table 21: Market Shares of Leading Analgesics Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......26
Table 22: Market Shares of Leading Analgesics Manufacturers in Africa Middle East (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......27
Table 23: Market Shares of Leading Analgesics Manufacturers in Asia-Pacific (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......28
Table 24: Market Shares of Leading Analgesics Manufacturers in Europe (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......29
Table 25: Market Shares of Leading Analgesic Product Manufacturers in India (2015) - Percentage Share Breakdown by Value for Emami Ltd., Glaxo SmithKline Consumer Healthcare Ltd., Reckitt Benckiser Group Plc, and Others......30
Table 26: Market Shares of Leading Analgesic Products Brands in India (2015) - Percentage Share Breakdown by Value for Zandu Balm & Mentha Balm, and Others......31
Table 27: Market Shares of Leading Analgesics Brands in Indonesia (2015) - Percentage Share Breakdown by Value for Bodrex (regular), Oskadon, Paramex, Puyer 16 and Others......32
Table 28: Market Shares of Leading Analgesics Brands in Indonesia (2015) - Percentage Share Breakdown by Volume for Bodrex (regular), Oskadon, Paramex, Puyer 16 and Others......33
Table 29: Market Shares of Leading Analgesics Manufacturers in Latin America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......34
Table 30: Market Shares of Leading Analgesic Brands in Nigeria (2015) - Percentage Breakdown by Value for Alabukun, Emzor, Pandol, and Others......35
Table 31: Market Shares of Leading Analgesics Manufacturers in North America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......36
Table 32: Market Shares of Leading Analgesic (Internal Tablet) Manufacturers by Value Sales at Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Bayer Consumer Health Division, McNeil Consumer Products, Pfizer, Inc., Private Label, and Others......37